FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Pfizer Zithromax Recall

Zithromax (azithromycin for injection), 500 mg/vial, Sterile, Rx Only, For I

Pfizer Inc. · New York, NY

Risk level
Class III
Reported by FDA
Jan 22, 2014
Recall ID
D-745-2014
Check your lot numberHow we source this data

Summary

Pfizer recalled Zithromax starting Jan 2, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-745-2014 on Jan 22, 2014. Reason: Failed Impurities/Degradation Specifications: Pfizer is recalling certain lots due to out of specification results for azithromycin N-oxide degradant. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Pfizer is recalling certain lots due to out of specification results for azithromycin N-oxide degradant.

Product description

Zithromax (azithromycin for injection), 500 mg/vial, Sterile, Rx Only, For I.V. infusion only, No latex, No preservative, Made in Ireland, Distributed by Pfizer Labs, Division of Pfizer Inc, NY, NY 10017, NDC 0069-3150-84

Lot numbers, UPCs & expiration codes

Lot Number/Expiration Date G81845, Exp 10/03/14 0B0CJ, Exp 02/06/15 G44710, Exp 07/10/15 G65241, Exp 07/11/15 G80003, Exp 10/17/15 G82722, Exp 11/27/15 G93028, G95309, Exp: 01/23/16 G97641, Exp 01/30/16

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-745-2014
Classification
Class III
Status
Terminated
Recall initiated
Jan 2, 2014
FDA report date
Jan 22, 2014
Quantity
101,681 Vials
Recall type
Voluntary: Firm initiated
Recalling firm
Pfizer Inc.

Original FDA data

Every field from FDA enforcement report D-745-2014, exactly as published.

Show all FDA fields
City
New York
State
NY
Status
Terminated
Country
United States
Event ID
67137
Address
235 East 42nd Street
Code information
Lot Number/Expiration Date G81845, Exp 10/03/14 0B0CJ, Exp 02/06/15 G44710, Exp 07/10/15 G65241, Exp 07/11/15 G80003, Exp 10/17/15 G82722, Exp 11/27/15 G93028, G95309, Exp: 01/23/16 G97641, Exp 01/30/16
Postal code
10017-5703
Report date
Jan 22, 2014
Product type
Drugs
Recall number
D-745-2014
Classification
Class III
Recalling firm
Pfizer Inc.
Product quantity
101,681 Vials
Termination date
Mar 14, 2016
Reason for recall
Failed Impurities/Degradation Specifications: Pfizer is recalling certain lots due to out of specification results for azithromycin N-oxide degradant.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Zithromax (azithromycin for injection), 500 mg/vial, Sterile, Rx Only, For I.V. infusion only, No latex, No preservative, Made in Ireland, Distributed by Pfizer Labs, Division of Pfizer Inc, NY, NY 10017, NDC 0069-3150-84
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Jan 2, 2014
Initial firm notification
Letter
Center classification date
Jan 16, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-745-2014, published Jan 22, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls